Publicacións en colaboración con investigadores/as de Hospital Costa Del Sol (3)

2023

  1. First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma

    Journal of Investigational Allergology and Clinical Immunology

  2. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 842-845

2012

  1. Omalizumab therapy in severe asthma: Experience from the Spanish registry - Some new approaches

    Journal of Asthma, Vol. 49, Núm. 4, pp. 416-422